Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Olga Kantor, M.D.

Title
Institution
Department
Address
Phone

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Kantor O, Chang C, Yao K, Boughey J, Roland C, Francescatti AB, Blair S, Dickson Witmer D, Hunt KK, Nelson H, Weiss A, Oseni T. Uptake of Breast Cancer Clinical Trials at Minority Serving Cancer Centers. Ann Surg Oncol. 2021 Jan 09. PMID: 33423122.
    Citations:    Fields:    
  2. Kantor O, King TA. ASO Author Reflections: Tailoring Axillary Surgery After Neoadjuvant Endocrine Therapy for Breast Cancer. Ann Surg Oncol. 2021 Mar; 28(3):1368-1369. PMID: 33389297.
    Citations:    Fields:    
  3. Kelly BN, Kantor O, Tang R, Coopey SB, Smith BL, Lanahan CR, Korotkin JE, Specht MC. Similar rates of residual disease in patients with DCIS within 2 mm of lumpectomy margin regardless of the presence of invasive carcinoma. Breast Cancer Res Treat. 2021 Apr; 186(3):807-814. PMID: 33247799.
    Citations:    Fields:    
  4. Kantor O, Coopey SB. Axillary Downstaging in ER+/HER2- Breast Cancer: OncotypeDX As a Tool to Guide Neoadjuvant Approach. Ann Surg Oncol. 2021 Mar; 28(3):1265-1267. PMID: 33230751.
    Citations: 1     Fields:    
  5. Losk K, Freedman RA, Laws A, Kantor O, Mittendorf EA, Tan-Wasielewski Z, Trippa L, Lin NU, Winer EP, King TA. Oncotype DX testing in node-positive breast cancer strongly impacts chemotherapy use at a comprehensive cancer center. Breast Cancer Res Treat. 2021 Jan; 185(1):215-227. PMID: 32939592.
    Citations: 1     Fields:    
  6. Kantor O, Wakeman M, Weiss A, Wong S, Laws A, Grossmith S, Mittendorf EA, King TA. Axillary Management After Neoadjuvant Endocrine Therapy for Hormone Receptor-Positive Breast Cancer. Ann Surg Oncol. 2021 Mar; 28(3):1358-1367. PMID: 32869154.
    Citations: 1     Fields:    Translation:Humans
  7. Kantor O, Wong S, Weiss A, Metzger O, Mittendorf EA, King TA. Prognostic significance of residual nodal disease after neoadjuvant endocrine therapy for hormone receptor-positive breast cancer. NPJ Breast Cancer. 2020; 6:35. PMID: 32821803.
    Citations: 3     
  8. Kantor O, Wong S, Weiss A, Metzger O, Mittendorf EA, King TA. Prognostic significance of residual nodal disease after neoadjuvant endocrine therapy for hormone receptor-positive breast cancer. NPJ Breast Cancer. 2020 Aug 13; 6(1):35. PMID: 33579920.
    Citations:    
  9. Minami CA, Kantor O, Weiss A, Nakhlis F, King TA, Mittendorf EA. Association Between Time to Operation and Pathologic Stage in Ductal Carcinoma in Situ and Early-Stage Hormone Receptor-Positive Breast Cancer. J Am Coll Surg. 2020 10; 231(4):434-447.e2. PMID: 32771654.
    Citations: 1     Fields:    Translation:HumansCellsPHPublic Health
  10. Laws A, Dillon K, Kelly BN, Kantor O, Hughes KS, Gadd MA, Smith BL, Lamb LR, Specht M. Node-Positive Patients Treated with Neoadjuvant Chemotherapy Can Be Spared Axillary Lymph Node Dissection with Wireless Non-Radioactive Localizers. Ann Surg Oncol. 2020 Nov; 27(12):4819-4827. PMID: 32740737.
    Citations: 3     Fields:    
  11. Laws A, Mulvey TM, Jalbert N, Dalton S, Kantor O, Harris KA, Krag KJ, Walsh EP, Coopey SB. Baseline Screening MRI Uptake and Findings in Women with =?20% Lifetime Risk of Breast Cancer. Ann Surg Oncol. 2020 Oct; 27(10):3595-3602. PMID: 32683633.
    Citations:    Fields:    
  12. Kantor O, Niu J, Zhao H, Giordano SH, Hunt KK, King TA, Mittendorf EA, Chavez-MacGregor M. Comparative Analysis of Proposed Strategies for Incorporating Biologic Factors into Breast Cancer Staging. Ann Surg Oncol. 2020 Jul; 27(7):2229-2237. PMID: 31916091.
    Citations: 2     Fields:    Translation:Humans
  13. Kantor O, Bao J, Jaskowiak N, Yao K, Tseng J. The Prognostic Value of the AJCC 8th Edition Staging System for Patients Undergoing Neoadjuvant Chemotherapy for Breast Cancer. Ann Surg Oncol. 2020 Feb; 27(2):352-358. PMID: 31376037.
    Citations: 1     Fields:    Translation:Humans
  14. Kantor O, Chang C, Bleicher RJ, Moran M, Connolly JL, Kurtzman SH, Yao K. Physician Knowledge of Breast Cancer Recurrence and Contralateral Breast Cancer Risk is Associated with Increased Recommendations for Contralateral Prophylactic Mastectomy: a Survey of Physicians at NAPBC-Accredited Centers. Ann Surg Oncol. 2019 Oct; 26(10):3080-3088. PMID: 31342369.
    Citations: 1     Fields:    Translation:Humans
  15. Kantor O, Barrera E, Kopkash K, Pesce C, Barrera E, Winchester DJ, Yao K. Are we Overtreating Hormone Receptor Positive Breast Cancer with Neoadjuvant Chemotherapy? Role of OncotypeDx® for Hormone Receptor Positive Patients Undergoing Neoadjuvant Chemotherapy. Ann Surg Oncol. 2019 Oct; 26(10):3232-3239. PMID: 31342379.
    Citations: 2     Fields:    Translation:Humans
  16. Kantor O, Pesce C, Kopkash K, Barrera E, Winchester DJ, Kuchta K, Yao K. Impact of the Society of Surgical Oncology-American Society for Radiation Oncology Margin Guidelines on Breast-Conserving Surgery and Mastectomy Trends. J Am Coll Surg. 2019 07; 229(1):104-114. PMID: 30902638.
    Citations: 3     Fields:    Translation:Humans
  17. Kantor O, Yao K. ASO Author Reflections: Bilateral Mastectomy After Neoadjuvant Therapy: An Ever-Increasing Trend? Ann Surg Oncol. 2018 12; 25(Suppl 3):650-651. PMID: 30327968.
    Citations:    Fields:    Translation:Humans
  18. Kantor O, James TA. ASO Author Reflections: Improving Patient Selection for Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy. Ann Surg Oncol. 2018 12; 25(Suppl 3):640-641. PMID: 30302645.
    Citations: 1     Fields:    Translation:Humans
  19. Kantor O, Pesce C, Liederbach E, Wang CH, Winchester DJ, Yao K. Author's response. Breast J. 2018 11; 24(6):1143. PMID: 30051547.
    Citations:    Fields:    Translation:Humans
  20. Kantor O, Wang CH, Yao K. Regional Variation in Performance for Commission on Cancer Breast Quality Measures and Impact on Overall Survival. Ann Surg Oncol. 2018 Oct; 25(10):3069-3075. PMID: 29956092.
    Citations: 3     Fields:    Translation:Humans
  21. Kantor O, Sipsy LM, Yao K, James TA. A Predictive Model for Axillary Node Pathologic Complete Response after Neoadjuvant Chemotherapy for Breast Cancer. Ann Surg Oncol. 2018 May; 25(5):1304-1311. PMID: 29368152.
    Citations: 13     Fields:    Translation:Humans
  22. Kantor O, Talamonti MS, Wang CH, Roggin KK, Bentrem DJ, Winchester DJ, Prinz RA, Baker MS. The extent of vascular resection is associated with perioperative outcome in patients undergoing pancreaticoduodenectomy. HPB (Oxford). 2018 02; 20(2):140-146. PMID: 29191690.
    Citations: 1     Fields:    Translation:Humans
  23. Kantor O, Ajmani G, Wang CH, Datta A, Yao K. The Shifting Paradigm for Breast Cancer Surgery in Patients Undergoing Neoadjuvant Chemotherapy. Ann Surg Oncol. 2018 Jan; 25(1):164-172. PMID: 29127538.
    Citations: 7     Fields:    Translation:Humans
  24. Ajmani GS, James TA, Kantor O, Wang CH, Yao KA. The Impact of Facility Volume on Rates of Pathologic Complete Response to Neoadjuvant Chemotherapy Used in Breast Cancer. Ann Surg Oncol. 2017 Oct; 24(11):3157-3166. PMID: 28685357.
    Citations: 1     Fields:    Translation:Humans
  25. Tseng J, Kyrillos A, Liederbach E, Spear GG, Ecanow J, Wang CH, Czechura T, Kantor O, Miller M, Winchester DJ, Pesce CE, Rabbitt S, Yao K. Clinical accuracy of preoperative breast MRI for breast cancer. J Surg Oncol. 2017 Jun; 115(8):924-931. PMID: 28409837.
    Citations: 5     Fields:    Translation:Humans
  26. Kantor O, Talamonti MS, Pitt HA, Vollmer CM, Riall TS, Hall BL, Wang CH, Baker MS. Using the NSQIP Pancreatic Demonstration Project to Derive a Modified Fistula Risk Score for Preoperative Risk Stratification in Patients Undergoing Pancreaticoduodenectomy. J Am Coll Surg. 2017 May; 224(5):816-825. PMID: 28408176.
    Citations: 10     Fields:    Translation:Humans
  27. Kantor O, Pesce C, Liederbach E, Wang CH, Winchester DJ, Yao K. Are the ACOSOG Z0011 Trial Findings Being Applied to Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy? Breast J. 2017 Sep; 23(5):554-562. PMID: 28295828.
    Citations: 1     Fields:    Translation:Humans
  28. Kantor O, Pesce C, Singh P, Miller M, Tseng J, Wang CH, Winchester DJ, Yao K. Post-mastectomy radiation therapy and overall survival after neoadjuvant chemotherapy. J Surg Oncol. 2017 May; 115(6):668-676. PMID: 28083910.
    Citations: 5     Fields:    Translation:Humans
  29. Lutfi W, Talamonti MS, Kantor O, Wang CH, Stocker SJ, Bentrem DJ, Roggin KK, Winchester DJ, Marsh R, Prinz RA, Baker MS. Neoadjuvant external beam radiation is associated with No benefit in overall survival for early stage pancreatic cancer. Am J Surg. 2017 Mar; 213(3):521-525. PMID: 28089341.
    Citations: 2     Fields:    Translation:Humans
  30. Kantor O, Talamonti MS, Lutfi W, Wang CH, Winchester DJ, Marsh R, Prinz RA, Baker MS. External radiation is associated with limited improvement in overall survival in resected margin-negative stage IIB pancreatic adenocarcinoma. Surgery. 2016 12; 160(6):1466-1476. PMID: 27614417.
    Citations: 2     Fields:    Translation:Humans
  31. Lutfi W, Talamonti MS, Kantor O, Wang CH, Liederbach E, Stocker SJ, Bentrem DJ, Roggin KK, Winchester DJ, Marsh R, Prinz RA, Baker MS. Perioperative chemotherapy is associated with a survival advantage in early stage adenocarcinoma of the pancreatic head. Surgery. 2016 09; 160(3):714-24. PMID: 27422328.
    Citations: 9     Fields:    Translation:Humans
  32. Miller ME, Kyrillos A, Yao K, Kantor O, Tseng J, Winchester DJ, Shulman LN. Utilization of Axillary Surgery for Patients With Ductal Carcinoma In Situ: A Report From the National Cancer Data Base. Ann Surg Oncol. 2016 10; 23(10):3337-46. PMID: 27334212.
    Citations: 3     Fields:    Translation:Humans
  33. Kantor O, Talamonti MS, Stocker SJ, Wang CH, Winchester DJ, Bentrem DJ, Prinz RA, Baker MS. A Graded Evaluation of Outcomes Following Pancreaticoduodenectomy with Major Vascular Resection in Pancreatic Cancer. J Gastrointest Surg. 2016 Feb; 20(2):284-92. PMID: 26493974.
    Citations: 3     Fields:    Translation:Humans
  34. In H, Kantor O, Sharpe SM, Baker MS, Talamonti MS, Posner MC. Adjuvant Therapy Improves Survival for T2N0 Gastric Cancer Patients with Sub-optimal Lymphadenectomy. Ann Surg Oncol. 2016 06; 23(6):1956-62. PMID: 26753752.
    Citations: 5     Fields:    Translation:Humans
  35. Kantor O, Pesce C, Liederbach E, Wang CH, Winchester DJ, Yao K. Surgery and hormone therapy trends in octogenarians with invasive breast cancer. Am J Surg. 2016 Mar; 211(3):541-5. PMID: 26768954.
    Citations: 6     Fields:    Translation:Humans
  36. Liederbach E, Wang CH, Lutfi W, Kantor O, Pesce C, Winchester DJ, Yao K. Survival Outcomes and Pathologic Features Among Breast Cancer Patients Who Have Developed a Contralateral Breast Cancer. Ann Surg Oncol. 2015 Dec; 22 Suppl 3:S412-21. PMID: 26334294.
    Citations: 1     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Kantor's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (100)
Explore
_
Co-Authors (20)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.